Abstract: New tetrazole-based pyrazole and pyrimidine derivatives were synthesized by an ultrasound irradiation method. All compounds were characterized by infrared spectroscopy (IR), 1 H nuclear magnetic resonance (NMR),
Introduction
Ultrasound-accelerated chemical reactions proceed via the formation and adiabatic collapse of transient cavitation bubbles. Ultrasound irradiation has become an alternative energy source for organic reactions ordinarily accomplished by heating. Many reactions can be conducted smoothly by sonication to provide improved yields and increased selectivity [1] .
Life-threatening invasive infections caused by microorganisms have increased to alarming levels all over the world [2] . In the past decades, antibiotics have been used as antimicrobial drugs. However, many human pathogens no longer respond to these antibiotics. Therefore, it is necessary to find new and efficacious drugs to treat these problems. The substitution of fluorine in potential drug molecules can improve their therapeutic efficacy through hydrogen bonding interactions at the active sites of the enzyme [3] . Thus, fluorine substitution remains an important aspect in the development of more active and selective drug candidates.
The synthetic versatility of tetrazole is due to its widespread applications in the field of medicinal chemistry. Tetrazole is considered a carboxylic acid analog because of their similar pK a values and planar delocalized systems. An advantage of tetrazole derivatives over carboxylic acids is that they are resistant to various biological degradation processes contributing to longer bioavailability of drugs [4, 5] . These factors, prime in the potential applications of tetrazole derivatives, are responsible for anticancer [6] , antifungal [7] , antitubercular [8] , anti-HIV [9] , antioxidant [10] and hormonal properties of the bioactive agents [11] . Pyrazole derivatives have showed significant biological activities, such as antimicrobial [12] , analgesic [13] , anti-inflammatory [14] and anticancer activities [15] . Pyrimidines also occupy a distinct and unique place in medicinal chemistry [16] . Pyrimidine derivatives are of interest due to their pharmacological properties such as antitumor [17] , antimalarial [18] , antiviral [19] , antifungal [20] , antibacterial [21] , anti-inflammatory [22] , analgesic [23] and antiprotozoal [24] activities. In continuation of our earlier work on design and synthesis of pharmacologically significant heterocycles [25] , herein we report an efficient green synthesis and antimicrobial activity of new tetrazole containing pyrazole and pyrimidine derivatives.
Results and discussion

Chemistry
New tetrazole-based pyrazole derivatives 8a-f and tetrazole-based pyrimidine derivatives 9a-f were synthesized using conventional heating and ultrasound irradiation methods (Scheme 1). The precursors 4a-f were prepared in good yield according to the literature procedure [26, 27] . Compounds 4a-f were converted into corresponding substituted 3-hydroxychromones 5a-f by oxidative cyclization using hydrogen peroxide in ethanol. The hydroxychromones 5a-f were alkylated with 2-chloroacetonitrile in the presence of K 2 CO 3 in N,N′-dimethylformamide (DMF) at room temperature to afford the substituted 2-(2-(4-fluorophenyl)-4-oxo-4H-chromen-3-yloxy)acetonitriles 6a-f. The reaction of 6a-f with sodium azide and zinc bromide in water at 100°C furnished 3-[(1H-tetrazol-5-yl)methoxy)-2-(4-fluorophenyl]-4H-chromen-4-one derivatives 7a-f. Treatment of 7a-f with hydrazine hydrate in ethanol under ultrasound irradiation yielded the desired pyrazoles 8a-f. In addition, treatment of compounds 7a-f with thiourea in ethanolic KOH under ultrasound irradiation furnished the desired pyrimidines 9a-f. All synthesized compounds were characterized by 1 H nuclear magnetic resonance (NMR), 13 C NMR, mass spectrometry (MS) and elemental analysis.
Antimicrobial activity
All compounds were evaluated for antibacterial activity against Gram-positive bacteria Staphylococcus aureus (NCIM 2079) and Bacillus subtilis (NCIM 2920) and Gramnegative bacteria Escherichia coli (NCIM 2065) and Pseudomonas aeruginosa (NCIM 2200) and for antifungal activity against Candida albicans (NCIM 3471) and Aspergillus niger (NCIM 596). The minimum inhibitory concentration (MIC) values were determined by the micro-broth dilution method. The antibacterial drug chloramphenicol and antifungal drug clotrimazole were used as reference antibiotics. The results are shown in Table 1 . Of interest are high activities of compounds 9a and 9e against A. niger. Compound 9e is also active against C. albicans. The activities of 8e, 9a and 9b against S. aureus exceed those of the reference drug chloramphenicol. Table 1 Antimicrobial screening results of bioactive compounds 8 and 9 using the micro-broth dilution method.
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Conclusion
Newly synthesized compounds 8e, 9a, 9b and 9e are highly potent antimicrobial agents.
Experimental
The progress of each reaction was monitored by thin-layer chromatography (TLC) using Merck silica gel 60 F 254 plates and visualized with ultraviolet (UV) light and iodine. Melting points were determined in open capillaries and are uncorrected. Infrared spectra were recorded on a Carry 600 Series Fourier-transform infrared spectroscopy (FT-IR) spectrophotometer using KBr pellets. 1 H NMR (400 MHz) and 13 C NMR (100 MHz) spectra were recorded on a Bruker AVANCE II 400 NMR spectrometer in CDCl 3 or DMSO-d 6 . Mass spectra were recorded on a Waters quadrupole time-of-flight (Q-TOF) micro instrument equipped with an electrospray ionization (ESI) source. Elemental analysis was performed on a Perkin-Elmer EAL-240 elemental analyzer.
General procedure for synthesis of compounds 5a-f
A mixture of (E)-3-(4-fluorophenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one (4a-f, 1 mmol), ethanol (15 mL), NaOH (10%, 5 mL) and hydrogen peroxide (30%, 1.5 mL) was stirred vigorously for 30 min and then kept for 2-3 h in ice. The progress of the reaction was monitored by TLC using ethyl acetate/hexane as an eluent. After completion of the reaction, the mixture was poured into ice water and acidified with 1 m hydrochloric acid (HCl). The precipitate was collected by filtration, washed with water and crystalized from chloroform/ethanol to afford a pure product. 
2-(4-
Fluorophenyl
2-(4-Fluorophenyl)-3-hydroxy-6-methyl-4H-chromen-4-one (5d) This compound was synthesized from (
E)-3-(4-fluorophenyl)- 1-(2-hydroxy-5-methylphenyl)prop-2-en-1-one (4d);
6,8-Dichloro-2-(4-fluorophenyl)-3-hydroxy-4H-chromen-4-one (5e) This compound was synthesized from (
E)-1-(3,5-dichloro- 2-hydroxyphenyl)-3-(4-fluorophenyl)prop-2-en-1-one (4e);
6-Chloro-2-(4-fluorophenyl)-3-hydroxy-7-methyl-4H-chromen-4-one (5f) This compound was synthesized from (
E)-1-(5-chloro- 2-hydroxy-4-methylphenyl)-3-(4-fluorophenyl)prop-2-en-1-one (4f);
General procedure for synthesis of compounds 6a-f
To a stirred solution of 5a-f (1 mmol) in DMF was added potassium carbonate (2 mmol) and portion-wise 2-chloroacetonitrile (1 mmol) at room temperature for about 3-4 h. The mixture was quenched with crushed ice and the resultant precipitate was filtered and crystallized from ethanol. 
2-(2-(4-Fluorophenyl)-4-oxo-4H-chromen-3-yloxy)acetonitrile (6a) This
General procedure for synthesis of compounds 7a-f
To a mixture of sodium azide (1.5 mmol) and zinc bromide (1.5 mmol) in water (20 mL) was added compound 6a-f (1 mmol). The mixture was then heated at reflux for 4-5 h with vigorous stirring. After completion of the reaction, as monitored by TLC using chloroform/ methanol as an eluent, the mixture was quenched with crushed ice, and the resultant solid was filtered and crystallized from ethanol. 1 (CH 3 ), 61.8 (O-CH 2 ), 115.4, 115.7, 120.6, 122.5 
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1606 (C=O), 1554 (C=C), 1238 (C-F) cm −1 ; 1 H NMR (DMSO-d 6 ): δ 5.47 (s, 2H
3-[(1H-Tetrazol-5-yl)methoxy]-2-(4-fluorophenyl)-8-methyl-4H-chromen-4-one (7c) This
3-[(1H-Tetrazol-5-yl)methoxy]-2-(4-fluorophenyl)-6-methyl-4H-chromen-4-one (7d) This
3-[(1H-Tetrazol-5-yl)methoxy]-6,8-dichloro-2-(4-fluorophenyl)-4H-chromen-4-one (7e) This
General procedure for synthesis of compounds 8a-f
Conventional method Hydrazine hydrate (1 mmol) was added to a solution of 7a-f (1 mmol) in ethanol (10 mL) and the mixture was heated for 5-6 h. After completion of the reaction, as monitored by TLC, 10 mL of water was added, and the resultant precipitate was filtered, dried under reduced pressure and crystallized from ethanol.
Ultrasound-assisted method Hydrazine hydrate (1 mmol) was added to a solution of 7a-f (1 mmol) in ethanol (10 mL) and the mixture was ultrasonicated for 45-55 min at 65°C. After completion of the reaction, as monitored by TLC, 10 mL of water was added, and the resultant precipitate was filtered, dried and crystallized from ethanol. 3346 (NH), 1865 (C=N), 1258 (C-F) Tetrazol-5-yl)methoxy]-5-(4-fluorophenyl)-1H-pyrazol-3-yl]-4,6-dichlorophenol (8e 
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General procedure for synthesis of compounds 9a-f
Conventional method To a mixture of compound 7a-f (1 mmol) and KOH (1.5 mmol) in ethanol (10 mL), thiourea (1.5 mmol) was added and the mixture was heated for 3-4 h. After completion of the reaction, as monitored by TLC, the reaction mass was cooled to room temperature, poured on crushed ice and acidified with concentrated HCl. The resultant solid was filtered and crystallized from ethanol.
Ultrasound-assisted method To a mixture of compound 7a-f (1 mmol) and KOH (1.5 mmol) in ethanol (10 mL), thiourea (1.5 mmol) was added and the reaction mass was ultrasonicated for 15-25 min at 65°C. After completion of the reaction, as monitored by TLC, the mixture was cooled to room temperature, poured on crushed ice and acidified with concentrated HCl. The resultant precipitate was filtered and crystallized from ethanol. 119.1, 120.0, 120.9, 129.5, 130.1, 130.5, 131.7, 135.5, 155.8, 157.9, 159.6 
5-[(1H-
Antimicrobial activity
Antibacterial activity of the synthesized compounds was tested in vitro against Gram-positive bacteria S. aureus (NCIM 2079) and B. subtilis (NCIM 2920) and Gram-negative bacteria E. coli (NCIM 2065) and P. aeruginosa (NCIM 2200). The compounds were also screened for antifungal activity against C. albicans (NCIM 3471) and A. niger (NCIM 596). Compounds were diluted in dimethyl sulfoxide (DMSO) with 1 μg/mL concentrations for bioassay. Micro-broth dilution method [28] was used to determine the MICs of compounds in 96-well microtiter plates. Test compounds were serially diluted in growth media. Plates were incubated at 30°C for fungi and 37°C for bacteria for 24 h. All experiments were carried out in triplicates.
